This is a preprint.
APOE, Immune Factors, Sex, and Diet Interact to Shape Brain Networks in Mouse Models of Aging
- PMID: 39005377
- PMCID: PMC11244909
- DOI: 10.1101/2023.10.04.560954
APOE, Immune Factors, Sex, and Diet Interact to Shape Brain Networks in Mouse Models of Aging
Abstract
Alzheimer's disease (AD) presents complex challenges due to its multifactorial nature, poorly understood etiology, and late detection. The mechanisms through which genetic, fixed and modifiable risk factors influence susceptibility to AD are under intense investigation, yet the impact of unique risk factors on brain networks is difficult to disentangle, and their interactions remain unclear. To model multiple risk factors including APOE genotype, age, sex, diet, and immunity we leveraged mice expressing the human APOE and NOS2 genes, conferring a reduced immune response compared to mouse Nos2. Employing graph analyses of brain connectomes derived from accelerated diffusion-weighted MRI, we assessed the global and local impact of risk factors in the absence of AD pathology. Aging and a high-fat diet impacted extensive networks comprising AD-vulnerable regions, including the temporal association cortex, amygdala, and the periaqueductal gray, involved in stress responses. Sex impacted networks including sexually dimorphic regions (thalamus, insula, hypothalamus) and key memory-processing areas (fimbria, septum). APOE genotypes modulated connectivity in memory, sensory, and motor regions, while diet and immunity both impacted the insula and hypothalamus. Notably, these risk factors converged on a circuit comprising 63 of 54,946 total connections (0.11% of the connectome), highlighting shared vulnerability amongst multiple AD risk factors in regions essential for sensory integration, emotional regulation, decision making, motor coordination, memory, homeostasis, and interoception. These network-based biomarkers hold translational value for distinguishing high-risk versus low-risk participants at preclinical AD stages, suggest circuits as potential therapeutic targets, and advance our understanding of network fingerprints associated with AD risk.
Significance statement: Current interventions for Alzheimer's disease (AD) do not provide a cure, and are delivered years after neuropathological onset. Addressing the impact of risk factors on brain networks holds promises for early detection, prevention, and revealing putative therapeutic targets at preclinical stages. We utilized six mouse models to investigate the impact of factors, including APOE genotype, age, sex, immunity, and diet, on brain networks. Large structural connectomes were derived from high resolution compressed sensing diffusion MRI. A highly parallelized graph classification identified subnetworks associated with unique risk factors, revealing their network fingerprints, and a common network composed of 63 connections with shared vulnerability to all risk factors. APOE genotype specific immune signatures support the design of interventions tailored to risk profiles.
Keywords: APOE; Alzheimer’s disease; Biological Sciences; MRI; Neuroscience; connectomics; mouse.
Conflict of interest statement
Competing Interest Statement: The authors have no conflicts to declare.
Figures



Similar articles
-
Brain network fingerprints of Alzheimer's disease risk factors in mouse models with humanized APOE alleles.Magn Reson Imaging. 2024 Dec;114:110251. doi: 10.1016/j.mri.2024.110251. Epub 2024 Oct 1. Magn Reson Imaging. 2024. PMID: 39362319
-
Identifying Vulnerable Brain Networks in Mouse Models of Genetic Risk Factors for Late Onset Alzheimer's Disease.Front Neuroinform. 2019 Dec 10;13:72. doi: 10.3389/fninf.2019.00072. eCollection 2019. Front Neuroinform. 2019. PMID: 31920610 Free PMC article.
-
Sex specific molecular networks and key drivers of Alzheimer's disease.Mol Neurodegener. 2023 Jun 20;18(1):39. doi: 10.1186/s13024-023-00624-5. Mol Neurodegener. 2023. PMID: 37340466 Free PMC article.
-
Age, APOE and sex: Triad of risk of Alzheimer's disease.J Steroid Biochem Mol Biol. 2016 Jun;160:134-47. doi: 10.1016/j.jsbmb.2016.03.012. Epub 2016 Mar 8. J Steroid Biochem Mol Biol. 2016. PMID: 26969397 Free PMC article. Review.
-
APOE-related biomarker profiles in non-pathological aging and early phases of Alzheimer's disease.Neurosci Biobehav Rev. 2013 Sep;37(8):1322-35. doi: 10.1016/j.neubiorev.2013.05.006. Epub 2013 May 20. Neurosci Biobehav Rev. 2013. PMID: 23701948 Review.
References
-
- TheAlzheimer’sAssociation, The Patient Journey in the Era of New Treatments, in https://www.alz.org/media/Documents/alzheimers-facts-and-figures.pdf. 2023.
-
- Corder E.H., et al., Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science, 1993. 261(5123): p. 921–3. - PubMed
-
- Raber J., Huang Y., and Ashford J.W., ApoE genotype accounts for the vast majority of AD risk and AD pathology. Neurobiology of Aging, 2004. 25(5): p. 641–650. - PubMed
-
- Mayeux R., et al., Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer’s disease. Alzheimer’s Disease Centers Consortium on Apolipoprotein E and Alzheimer’s Disease. N Engl J Med, 1998. 338(8): p. 506–11. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous